≡ Risteys
R13

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Carcinoma in situ of penis

DOID EFO Endpoint Browser

CD2_INSITU_PENIS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

only males

226754

2. Check conditions

  • not C3_PENIS
226622

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D07.4&
  • Hospital discharge: ICD-9 — 2335
  • Cause of death: ICD-10 — D07.4&
  • Cause of death: ICD-9 — 2335
  • Cancer registry: Topography ICD-O-3 — C60
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 2

3 out of 7 registries used, show all original rules.

61

4. Check minimum number of events

None

61

5. Include endpoints

None

61

6. Filter based on genotype QC (FinnGen only)

58

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9
Parent code in ICD-10
D07
Name in latin
Carcinoma in situ vesicae urinariae

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 58 - 58
Unadjusted period prevalence (%) 0.03 - 0.03
Median age at first event (years) 66.19 - 66.19

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
61
Matched controls
610
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D07.4
ICD-10 Finland
Carcinoma in situ: Penis
+∞
68.0
52
*
KGB00
NOMESCO Finland
Biopsy of penis
97.4
14.3
15
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
9.7
10.0
21
31
N48.1
ICD-10 Finland
Balanoposthitis
16.1
8.9
14
11
KGD10
NOMESCO Finland
Destruction of lesion of penis
+∞
8.5
8
*
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
+∞
8.5
8
*
KGH10
NOMESCO Finland
Operation for phimosis
11.7
7.8
14
15
C60.1
ICD-10 Finland
Malignant neoplasm: Glans penis
90.7
7.6
8
*
L43.8
ICD-10 Finland
Other lichen planus
+∞
7.4
7
*
D06BB10
ATC
imiquimod; topical
11.4
7.2
13
14
E0000UV, ,
ATC
4.2
7.0
34
142
8070/2-C60.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of penis, NOS
+∞
6.3
6
*
XKD00
NOMESCO Finland
Uroflowmetry
3.8
6.0
27
105

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
17
22
10.25
8.61
1.6
1.1
—
—
—
0
0
38
188
3.71
5.84
3.5
2.2
—
—
—
0
0
22
81
3.68
5.21
1.7
2.7
—
—
—
0
0
20
70
3.76
5.09
1.5
1.3
—
—
—
0
0
15
53
3.43
3.67
1.6
1.4
—
—
—
0
0
17
66
3.18
3.59
1.3
1.9
—
—
—
0
0
5
6
8.93
2.80
4.2
1.5
—
—
—
0
0
22
113
2.48
2.70
14.0
7.3
—
—
—
0
0
32
196
2.33
2.65
2.3
1.9
94.60
86.58
pmol/l
0.33
18
116
27
155
2.33
2.58
3.4
3.2
—
—
—
0
0
36
234
2.31
2.57
11.9
7.3
—
—
—
0
0
37
247
2.27
2.43
9.1
6.3
0.66
0.65
e9/l
0.12
31
217
37
247
2.27
2.43
9.1
6.4
0.04
0.04
e9/l
0.04
31
218
37
252
2.19
2.26
10.2
6.9
0.21
0.20
e9/l
0.10
32
225
18
91
2.39
2.24
3.3
2.3
16.04
12.87
umol/l
0.65
18
83
25
146
2.21
2.24
4.4
3.0
—
—
—
0
0
8
25
3.52
2.18
2.9
3.7
—
—
—
0
0
8
25
3.52
2.18
2.4
2.5
—
—
—
0
0
32
216
2.01
1.90
12.2
13.4
0.00
0.01
e9/l
0.51
26
181
8
167
0.40
1.85
3.1
3.2
—
—
—
0
0
11
48
2.58
1.83
2.5
1.5
—
—
—
0
0
5
13
4.09
1.75
1.6
1.3
—
—
—
0
0
16
86
2.17
1.70
3.3
2.2
2.25
2.24
g/l
0.03
16
76
15
79
2.19
1.67
3.7
2.2
28.46
23.89
%
0.40
15
69
14
72
2.23
1.65
1.4
1.5
—
—
—
0
0
5
14
3.79
1.65
1.4
1.1
—
—
—
0
0
28
191
1.86
1.53
5.3
3.6
39.67
49.19
e6/l
0.11
23
135
17
100
1.97
1.42
3.2
3.6
29.58
151.30
ng/l
1.67
12
83
26
181
1.76
1.28
7.3
5.4
—
—
—
0
0
47
389
1.91
1.27
14.0
8.9
86.55
79.68
u/l
0.43
42
372
38
296
1.75
1.26
7.2
4.2
—
5.60
—
0
5
0
35
0.00
1.19
0.0
1.3
—
—
—
0
0
8
40
2.15
1.17
2.0
2.3
99.13
230.03
ng/l
—
8
34
17
108
1.80
1.12
2.8
2.8
4.15
2.81
e6/l
0.35
17
93
5
21
2.50
1.11
1.8
1.2
—
—
—
0
0
9
48
2.02
1.06
8.3
10.2
—
—
—
0
0
5
22
2.38
1.05
8.6
38.3
—
—
—
0
0
40
327
1.65
1.01
6.2
4.2
—
—
—
0
0
0
31
0.00
0.99
0.0
13.8
—
—
—
0
0
29
220
1.61
0.99
4.0
4.1
33.70
38.32
ng/l
0.16
22
169
6
31
2.03
0.87
8.8
4.3
—
—
—
0
0
34
274
1.54
0.86
17.4
16.0
1.40
1.32
inr
—
8
86
10
58
1.87
0.85
1.6
2.1
—
—
—
0
0
53
481
1.78
0.74
31.8
18.1
36.69
27.03
mg/l
0.62
46
401
10
61
1.76
0.74
5.7
20.1
0.23
1.62
mmol/l
—
10
47
7
41
1.80
0.73
7.1
3.1
—
—
—
0
0
7
41
1.80
0.73
8.4
4.3
—
7.41
—
0
5
7
42
1.75
0.71
1.0
1.3
—
—
—
0
0
5
27
1.93
0.70
5.4
2.8
1621.20
615.28
ug/l
—
5
27
8
52
1.62
0.62
3.4
1.6
—
—
—
0
0
8
54
1.55
0.60
1.6
1.3
—
—
—
0
0
12
83
1.55
0.57
1.7
1.3
2.09
2.57
g/l
—
5
51
6
38
1.64
0.56
6.0
7.4
23.67
25.10
mmol/l
—
6
38
6
39
1.60
0.55
2.7
1.4
—
—
—
0
0
9
64
1.48
0.54
1.3
1.3
—
—
—
0
0
43
383
1.42
0.53
5.7
5.0
3.43
3.39
ug/l
0.01
37
347
16
121
1.44
0.51
1.3
1.3
—
—
—
0
0
15
115
1.40
0.44
4.5
2.8
—
—
—
0
0
39
348
1.33
0.44
4.6
4.5
—
—
—
0
0
0
17
0.00
0.41
0.0
2.7
—
2.91
—
0
10
0
17
0.00
0.41
0.0
2.7
—
8.16
—
0
17
0
17
0.00
0.41
0.0
2.7
—
5.11
—
0
17
10
72
1.47
0.40
1.3
1.2
—
0.84
—
0
18
7
52
1.39
0.32
7.4
23.0
121.57
123.58
g/l
—
7
52
7
53
1.36
0.32
1.7
1.6
—
—
—
0
0
11
136
0.77
0.26
2.5
3.3
—
—
—
0
0
48
453
1.28
0.26
4.4
4.3
1.50
1.30
mmol/l
0.43
42
416
15
126
1.25
0.24
3.3
2.7
—
—
—
0
0
5
38
1.34
0.24
5.8
18.8
—
—
—
0
0
49
466
1.26
0.23
5.1
4.7
1.26
1.30
mmol/l
0.35
44
427
10
80
1.30
0.22
6.6
9.4
103.00
103.67
mmol/l
—
10
80
0
11
0.00
0.21
0.0
1.3
—
0.23
—
0
11
0
10
0.00
0.21
0.0
1.9
—
1.54
—
0
10
0
10
0.00
0.21
0.0
3.4
—
—
—
0
0
0
10
0.00
0.21
0.0
3.4
—
4.05
—
0
10
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
3.4
—
105.10
—
0
10
0
12
0.00
0.21
0.0
1.4
—
1.03
—
0
12
6
48
1.28
0.21
1.2
3.0
63.55
65.96
g/l
—
6
43
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
5.5
—
1.65
—
0
13
0
13
0.00
0.21
0.0
5.5
—
7.31
—
0
13
0
14
0.00
0.20
0.0
3.1
—
14.97
—
0
7
0
14
0.00
0.20
0.0
2.9
—
122.25
—
0
8
6
52
1.17
0.20
7.3
5.3
—
—
—
0
0
51
493
1.21
0.14
24.9
17.7
—
—
—
0
0
5
47
1.07
0.09
10.0
4.6
0.62
2.07
mmol/l
—
5
36
6
57
1.06
0.09
2.8
2.8
11.95
10.32
ug/l
—
6
51
17
160
1.09
0.05
7.8
4.8
—
—
—
0
0
17
172
0.98
0.00
5.8
4.1
19.20
9.09
mg/mmol
0.32
12
120
0
6
0.00
0.00
0.0
12.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
5.0
—
6.48
—
0
6
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
199.11
—
0
9
6
63
0.95
-0.00
2.2
5.1
2.62
75.74
ug/l
—
6
53
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
9.40
—
0
5
0
8
0.00
-0.00
0.0
1.6
—
4.89
—
0
8
0
5
0.00
-0.00
0.0
9.6
—
584.80
—
0
5
0
9
0.00
-0.00
0.0
2.2
—
59.33
—
0
9
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
6.2
—
3.15
—
0
5
0
7
0.00
-0.00
0.0
11.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
16.8
—
1065.80
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.2
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_INSITU_PENIS – Carcinoma in situ of penis

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).